Literature DB >> 32078687

A new role for an old cytokine: GM-CSF amplifies GVHD.

Edmund K Waller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32078687      PMCID： PMC7033371          DOI： 10.1182/blood.2019004681

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

Authors:  F Stephen Hodi; Sandra Lee; David F McDermott; Uma N Rao; Lisa H Butterfield; Ahmad A Tarhini; Philip Leming; Igor Puzanov; Donghoon Shin; John M Kirkwood
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation.

Authors:  Kate A Markey; Tatjana Banovic; Rachel D Kuns; Stuart D Olver; Alistair L J Don; Neil C Raffelt; Yana A Wilson; Liza J Raggatt; Allison R Pettit; Jonathan S Bromberg; Geoffrey R Hill; Kelli P A MacDonald
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

3.  GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.

Authors:  Rosalie M Sterner; Reona Sakemura; Michelle J Cox; Nan Yang; Roman H Khadka; Cynthia L Forsman; Michael J Hansen; Fang Jin; Katayoun Ayasoufi; Mehrdad Hefazi; Kendall J Schick; Denise K Walters; Omar Ahmed; Dale Chappell; Tarek Sahmoud; Cameron Durrant; Wendy K Nevala; Mrinal M Patnaik; Larry R Pease; Karen E Hedin; Neil E Kay; Aaron J Johnson; Saad S Kenderian
Journal:  Blood       Date:  2018-11-21       Impact factor: 22.113

4.  Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β.

Authors:  Juliana Komuczki; Selma Tuzlak; Ekaterina Friebel; Tom Hartwig; Sabine Spath; Philip Rosenstiel; Ari Waisman; Lennart Opitz; Mohammed Oukka; Bettina Schreiner; Pawel Pelczar; Burkhard Becher
Journal:  Immunity       Date:  2019-05-09       Impact factor: 31.745

5.  Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

Authors:  Igal Ifergan; Todd S Davidson; Hania Kebir; Dan Xu; Daphne Palacios-Macapagal; Jennifer Cann; Jane M Rodgers; Zoe N Hunter; Camille L Pittet; Sara Beddow; Clare A Jones; Alexandre Prat; Matthew A Sleeman; Stephen D Miller
Journal:  J Autoimmun       Date:  2017-06-20       Impact factor: 7.094

6.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

7.  Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.

Authors:  R Nishinakamura; A Miyajima; P J Mee; V L Tybulewicz; R Murray
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

8.  Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.

Authors:  Clint Piper; Vivian Zhou; Richard Komorowski; Aniko Szabo; Benjamin Vincent; Jonathan Serody; Maria-Luisa Alegre; Brian T Edelson; Reshma Taneja; William R Drobyski
Journal:  Blood       Date:  2020-02-20       Impact factor: 22.113

9.  Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.

Authors:  Chih-Chung Lin; Tara R Bradstreet; Elizabeth A Schwarzkopf; Julia Sim; Javier A Carrero; Chun Chou; Lindsey E Cook; Takeshi Egawa; Reshma Taneja; Theresa L Murphy; John H Russell; Brian T Edelson
Journal:  Nat Commun       Date:  2014-04-03       Impact factor: 14.919
  9 in total
  3 in total

1.  Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantation.

Authors:  Yiouli P Ktena; Michael A Koldobskiy; Michael I Barbato; Han-Hsuan Fu; Leo Luznik; Nicolas J Llosa; Azeb Haile; Orly R Klein; Chen Liu; Christopher J Gamper; Kenneth R Cooke
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

Review 2.  Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.

Authors:  Qingxiao Song; Ubaydah Nasri; Ryotaro Nakamura; Paul J Martin; Defu Zeng
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

3.  Immune Tolerance as the Physiologic Counterpart of Chronic Inflammation.

Authors:  Vladimir Rogovskii
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.